Han T, Cheng T, Liao Y, He Y, Liu B, Lai Q, . . . Cao Y. (2022). Development and Validation of a Novel Prognostic Score Based on Thrombotic and Inflammatory Biomarkers for Predicting 28-Day Adverse Outcomes in Patients with Acute Pancreatitis. Dove Medical Press.
Chicago Style (17th ed.) CitationHan T, et al. Development and Validation of a Novel Prognostic Score Based on Thrombotic and Inflammatory Biomarkers for Predicting 28-Day Adverse Outcomes in Patients with Acute Pancreatitis. Dove Medical Press, 2022.
MLA (9th ed.) CitationHan T, et al. Development and Validation of a Novel Prognostic Score Based on Thrombotic and Inflammatory Biomarkers for Predicting 28-Day Adverse Outcomes in Patients with Acute Pancreatitis. Dove Medical Press, 2022.
Warning: These citations may not always be 100% accurate.